Extrapulmonary manifestations of COVID-19
Recent clinical observations have prompted clinicians to think of COVID-19 as being more than a respiratory disease.
Recent clinical observations have prompted clinicians to think of COVID-19 as being more than a respiratory disease.
Toni Choueiri: The February ASCO Plenary Series are here / ASCO, ASCO Plenary Series, cancer, DREAMM-7, FRUTIGA, gastric/GE junction adenocarcinoma,
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Dr. Nazli Dizman has traveled across the world to pursue her passion for clinical and translational cancer research and further her career as a medical…
KCRS is the annual Kidney Cancer Research Summit presented by KidneyCAN. KCRS is a meeting focused on basic and translational science, as well as cutting…
Abstract 51Characterization of FOLH1 Expression in Renal Cell Carcinoma Eric Ovruchesky, Elizabeth Pan, Andrew Elliott, Shankar Siva, Praful Ravi, Brad McGregor, Toni Choueiri, Aditya Bagrodia,…
We’re hosting a fun 5K in Boston on July 14th at the Kidney Cancer Research Summit, but you’re invited to participate wherever you are and…
Given the central role of the androgen receptor (AR) in prostate cancer cell biology, AR-targeted therapies have been the backbone of prostate cancer treatment for…